Mitsubishi UFJ Morgan Stanley Securities’s Gilead Sciences GILD Stock Holding History

Mitsubishi UFJ Morgan Stanley Securities’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$60.5K	Sell	479 -891	-65%	-$117K	0.19%	133
2026 Q1	$191K	Sell	1,370 -710	-34%	-$99.4K	0.47%	70
2025 Q4	$255K	Buy	+2,080	New	+$253K	0.4%	61
2023 Q1	–	Sell	-590	Closed	-$51K	–	92
2022 Q4	$51K	Buy	590 +310	+111%	+$24.5K	0.45%	25
2022 Q3	$17K	Hold	280	–	–	0.23%	76
2022 Q2	$17K	Hold	280	–	–	0.02%	80
2022 Q1	$17K	Buy	+280	New	+$17.9K	0.01%	91
2014 Q4	$271K	Buy	2,870 +70	+3%	+$7.24K	0.56%	8
2014 Q3	$298K	Sell	2,800 -3,920	-58%	-$384K	0.85%	10
2014 Q2	$557K	Buy	6,720 +4,060	+153%	+$316K	1.63%	6
2014 Q1	$188K	Sell	2,660 -780	-23%	-$61.2K	0.5%	10
2013 Q4	$258K	Buy	3,440 +810	+31%	+$56.4K	0.43%	9
2013 Q3	$165K	Buy	2,630 +1,020	+63%	+$61K	0.27%	12
2013 Q2	$83K	Buy	+1,610	New	+$83.9K	0.28%	35

Other funds holding GILD

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

CGH

Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Mitsubishi UFJ Morgan Stanley Securities's GILD Position: Q2 2026 in Review

Mitsubishi UFJ Morgan Stanley Securities reduced its Gilead Sciences (GILD) stake by 65% in Q2 2026, selling an estimated $117K and leaving 479 shares worth $60.5K. The position accounts for 0.19% of the portfolio, ranked #133.

Mitsubishi UFJ Morgan Stanley Securities first reported a position in GILD in Q2 2013 and has held it in 14 quarters since. The position peaked at $557K in Q2 2014. 836 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Mitsubishi UFJ Morgan Stanley Securities held 479 shares of Gilead Sciences worth $60.5K as of Q2 2026.
Mitsubishi UFJ Morgan Stanley Securities sold 891 Gilead Sciences shares in Q2 2026, an estimated $117K.
Gilead Sciences made up 0.19% of Mitsubishi UFJ Morgan Stanley Securities's portfolio in Q2 2026, its #133 holding.
Mitsubishi UFJ Morgan Stanley Securities first reported a position in Gilead Sciences in Q2 2013 and has held it in 14 quarters since.
Mitsubishi UFJ Morgan Stanley Securities's Gilead Sciences position peaked at $557K in Q2 2014.
836 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Mitsubishi UFJ Morgan Stanley Securities's 13F filing for Q2 2026, filed 15 Jul 2026.